Eli Lilly Leads Obesity Drug Market Battles
Reading
The market for obesity and diabetes is very strong. Many companies want to sell treatments for these diseases. Eli Lilly makes a lot of money from these treatments, and others want to join them.
Eli Lilly said its drugs Mounjaro and Zepbound sell well. These drugs made over $10 billion in the last three months. That is more than half of the company's total sales of $17.6 billion.
Novo Nordisk wants to buy Metsera Inc. This deal could cost up to $9 billion. Pfizer also wanted to buy Metsera, but Novo Nordisk offered more money.
These popular drugs copy hormones in the body. They help people feel full and control their appetite. But they do not work for everyone and can cause stomach problems.
Eli Lilly's weight-loss drug sales grew a lot. The diabetes drug also sold more in other countries. These drugs made almost $25 billion for Eli Lilly this year, which is more than in 2020.
Questions
What diseases are companies trying to sell treatments for?
Companies are trying to sell treatments for obesity and diabetes.
How much money did Eli Lilly's drugs Mounjaro and Zepbound make in the last three months?
They made over $10 billion in the last three months.
What do these popular drugs do in the body?
They copy hormones in the body to help people feel full and control their appetite.
Describe the article image
Look at the article image and describe what you see on it. You may either speak or write your answer there.
Discussion
Discuss this article with your AI tutor to practice. Your tutor will help you with vocabulary and grammar.
Read a new article every day anddiscuss it with AI at lingolette.com